Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Jimenez

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Gland Surgery|March 14, 2023
Accuracy of sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trialMaria Vernet-Tomás, Nuria Argudo, Marta Jimenez, et al.
Journal of Adolescent and Young Adult Oncology|November 9, 2019
Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 YearsPerrine Marec-Berard, Valérie Laurence, Bob-Valéry Occean, et al.
Oncoimmunology|September 22, 2017
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trialAnne Gomez-Brouchet, Claire Illac, Julia Gilhodes, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcomeAlice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
Journal of Sleep Research|November 25, 2017
The prevalence of narcolepsy in Catalunya (Spain)Ester Tió, Carles Gaig, Maria Giner-Soriano, et al.
British Journal of Cancer|September 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosisAbderaouf Hamza, Pierre Gestraud, Maryam Karimi, et al.
British Journal of Cancer|August 1, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitorsMarie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, et al.
JACC. Heart Failure|March 2, 2024
Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF TrialJesus Alvarez-Garcia, Anuradha Lala, Mercedes Rivas-Lasarte, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 11, 2026
The Top 12 Most Impactful Papers in Clinical Transplantation in 2025: TI Editors' ChoiceThierry Berney, Chiara Becchetti, Maria Irene Bellini, et al.
Cancer Research|January 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at DiagnosisAntonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Gland Surgery|March 14, 2023
Accuracy of sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trialMaria Vernet-Tomás, Nuria Argudo, Marta Jimenez, et al.
Journal of Adolescent and Young Adult Oncology|November 9, 2019
Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 YearsPerrine Marec-Berard, Valérie Laurence, Bob-Valéry Occean, et al.
Oncoimmunology|September 22, 2017
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trialAnne Gomez-Brouchet, Claire Illac, Julia Gilhodes, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcomeAlice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
Journal of Sleep Research|November 25, 2017
The prevalence of narcolepsy in Catalunya (Spain)Ester Tió, Carles Gaig, Maria Giner-Soriano, et al.
British Journal of Cancer|September 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosisAbderaouf Hamza, Pierre Gestraud, Maryam Karimi, et al.
British Journal of Cancer|August 1, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitorsMarie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, et al.
JACC. Heart Failure|March 2, 2024
Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF TrialJesus Alvarez-Garcia, Anuradha Lala, Mercedes Rivas-Lasarte, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 11, 2026
The Top 12 Most Impactful Papers in Clinical Transplantation in 2025: TI Editors' ChoiceThierry Berney, Chiara Becchetti, Maria Irene Bellini, et al.
Cancer Research|January 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at DiagnosisAntonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, et al.
Pageof 8